Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The influenza virus RNA polymerase complex contains a cap-dependent endonuclease located in the N-terminal domain of the PA subunit (PA-N). This enzyme is essential for viral mRNA synthesis via a "cap-snatching" mechanism, where it cleaves host pre-mRNAs to generate capped RNA primers. PB2 subunit binds the cap, PA subunit cleaves the RNA. This activity is a validated antiviral drug target.
Inhibition of endonucleolytic cleavage of host capped RNAs
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza Virus Cap-dependent Endonuclease (PA-N domain) (PA-N).